Pinokio

RVNC retracement and consolidation

Short
NASDAQ:RVNC   Revance Therapeutics, Inc.
RVNC jumped on a successful phase 3 clinical trials. It held its ground however there was a blow of top and retracement.
(for education purposes)
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.